Format

Send to

Choose Destination
See comment in PubMed Commons below
Tuberc Respir Dis (Seoul). 2012 Sep;73(3):137-42. doi: 10.4046/trd.2012.73.3.137. Epub 2012 Sep 28.

Year-in-Review of Lung Cancer.

Author information

1
Department of Internal Medicine, Konyang University Hospital, Konyang University College of Medicine, Daejeon, Korea.

Abstract

In the last several years, we have made slow but steady progress in understanding molecular biology of lung cancer. This review is focused on advances in understanding the biology of lung cancer that have led to proof of concept studies on new therapeutic approaches. The three selected topics include genetics, epigenetics and non-coding RNA. This new information represents progress in the integration of molecular mechanisms that to identify more effective ways to target lung cancer.

KEYWORDS:

Epigenomics; Genetics; Lung Neoplasms; Molecular Biology; RNA, Untranslated

PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for The Korean Academy of Tuberculosis and Respiratory Diseases Icon for PubMed Central
    Loading ...
    Support Center